Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,950 | 193 | 99.8% |
| Education | $15.64 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,552 | 48 | $0 (2024) |
| ABBVIE INC. | $1,041 | 28 | $0 (2024) |
| Lilly USA, LLC | $757.80 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $745.49 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $644.82 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $481.96 | 7 | $0 (2024) |
| Gilead Sciences, Inc. | $438.70 | 4 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $298.64 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $296.96 | 5 | $0 (2024) |
| Amgen Inc. | $273.77 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,058 | 46 | AstraZeneca Pharmaceuticals LP ($396.01) |
| 2023 | $2,832 | 63 | Bayer Healthcare Pharmaceuticals Inc. ($479.83) |
| 2022 | $1,502 | 38 | Novo Nordisk Inc ($392.90) |
| 2021 | $1,574 | 48 | Novo Nordisk Inc ($411.42) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $108.27 | General |
| Category: Respiratory | ||||||
| 09/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $82.92 | General |
| Category: Women's Health | ||||||
| 08/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $96.30 | General |
| 08/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $88.51 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardiology | ||||||
| 05/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Obesity | ||||||
| 04/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $103.94 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.73 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 338 | 508 | $58,435 | $21,421 |
| 2022 | 9 | 219 | 327 | $37,010 | $13,659 |
| 2021 | 8 | 226 | 312 | $31,995 | $11,298 |
| 2020 | 6 | 165 | 254 | $31,095 | $9,477 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 213 | $34,080 | $12,041 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 32 | 32 | $8,000 | $3,555 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 28 | $6,720 | $2,379 | 35.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 19 | 19 | $2,850 | $914.40 | 32.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 57 | 83 | $1,245 | $697.20 | 56.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 18 | $1,710 | $663.34 | 38.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $625.00 | $393.75 | 63.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $575.00 | $362.25 | 63.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 31 | $1,550 | $292.03 | 18.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 33 | 36 | $1,080 | $122.76 | 11.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 140 | $22,400 | $8,200 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 24 | $5,760 | $2,049 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $4,000 | $1,820 | 45.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 21 | $1,995 | $762.21 | 38.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 14 | 14 | $350.00 | $226.87 | 64.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 14 | 14 | $350.00 | $222.90 | 63.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 67 | $1,005 | $197.91 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $550.00 | $111.42 | 20.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 19 | 20 | $600.00 | $68.58 | 11.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 139 | $22,240 | $7,508 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 18 | 18 | $4,500 | $2,105 | 46.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 20 | $1,900 | $712.50 | 37.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 20 | 20 | $500.00 | $325.60 | 65.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 17 | 17 | $425.00 | $276.76 | 65.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 42 | 54 | $810.00 | $162.00 | 20.0% |
About Judy Barrett, NURSE PRACTITIONER
Judy Barrett, NURSE PRACTITIONER is a Nurse Practitioner healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2019. The National Provider Identifier (NPI) number assigned to this provider is 1235773029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Judy Barrett, NURSE PRACTITIONER has received a total of $7,966 in payments from pharmaceutical and medical device companies, with $2,058 received in 2024. These payments were reported across 195 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,950).
As a Medicare-enrolled provider, Barrett has provided services to 948 Medicare beneficiaries, totaling 1,401 services with total Medicare billing of $55,855. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Palm Beach Gardens, FL
- Active Since 11/04/2019
- Last Updated 12/31/2019
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235773029
Products in Payments
- Kerendia (Drug) $644.82
- MOUNJARO (Drug) $619.58
- Ozempic (Drug) $461.50
- QULIPTA (Drug) $455.39
- UBRELVY (Drug) $377.91
- Wegovy (Drug) $361.13
- QUVIVIQ (Drug) $298.64
- Rybelsus (Drug) $277.05
- AIRSUPRA (Drug) $271.02
- BREZTRI (Drug) $249.99
- JARDIANCE (Drug) $231.74
- FARXIGA (Drug) $213.93
- Biktarvy (Drug) $205.65
- VRAYLAR (Drug) $191.04
- Repatha (Biological) $168.42
- RYBELSUS (Drug) $152.06
- Impella (Device) $149.08
- NEXLETOL (Drug) $142.71
- AREXVY (Drug) $141.32
- KRYSTEXXA (Biological) $138.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Palm Beach Gardens
Newah Mofor-Tawo
Nurse Practitioner — Payments: $12,802
Geraldine Emanuel, Arnp, ARNP
Nurse Practitioner — Payments: $9,163
Kathryn Chambers, Aocnp, AOCNP
Nurse Practitioner — Payments: $8,850
Shanna Stone, Arnp, ARNP
Nurse Practitioner — Payments: $7,272
Casey Turek
Nurse Practitioner — Payments: $6,279
Mrs. Tara Smith, Arnp, ARNP
Nurse Practitioner — Payments: $5,949